Alkeon Capital Management LLC Cabaletta Bio, Inc. Transaction History
Alkeon Capital Management LLC
- $60.9 Billion
- Q2 2024
A detailed history of Alkeon Capital Management LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Alkeon Capital Management LLC holds 2,618,000 shares of CABA stock, worth $10.7 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,618,000
Previous 500,000
423.6%
Holding current value
$10.7 Million
Previous $8.53 Million
129.57%
% of portfolio
0.03%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding CABA
# of Institutions
145Shares Held
50.1MCall Options Held
19.9KPut Options Held
41.5K-
Jennison Associates LLC5.55MShares$22.6 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.76MShares$19.4 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.88MShares$15.8 Million0.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$12.4 Million0.04% of portfolio
-
Fred Alger Management, LLC New York, NY2.52MShares$10.3 Million0.09% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $118M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...